<DOC>
	<DOCNO>NCT00924742</DOCNO>
	<brief_summary>The purpose study examine pharmacokinetic property Tapimycin injection ( piperacillin 4 g + tazobactam 0.5 g powder injection ) healthy volunteer fast condition .</brief_summary>
	<brief_title>A Single-Dose Pharmacokinetics Study Tapimycin Injection</brief_title>
	<detailed_description />
	<mesh_term>Tazobactam</mesh_term>
	<mesh_term>Penicillanic Acid</mesh_term>
	<mesh_term>Piperacillin</mesh_term>
	<criteria>1 . Provision sign write informed consent enrollment study , ability communicate investigator , understand comply requirement study . 2 . Healthy adult male , age 20 40 year old . 3 . Body Mass Index ( BMI ) 18.5 25 . 4 . Physically mentally healthy subject confirm interview , medical history , clinical examination , chest xray electrocardiogram . 5 . No significant deviation normal biochemistry . 6 . No significant deviation normal hematology . 7 . No significant deviation normal urinalysis . 1 . History drug alcohol abuse within past year . 2 . Medical history severe drug allergy sensitivity analogous drug . 3 . Acute chronic disease undergo surgery 4 week prior PeriodI dose . 4 . Any clinical significant renal , cardiovascular , hepatic , hematopoietic , neurological , pulmonary gastrointestinal pathology . 5 . Ongoing peptic ulcer constipation . 6 . Planned vaccination time course study . 7 . Taking clinical study drug 3 month prior Period I dose . 8 . Use medication , include herb medicine vitamins 4 week study . 9 . Blood donation 500 mL within past 3 month . 10 . A positive Hepatitis B surface antigen positive Hepatitis C antibody . 11 . A positive test HIV antibody .</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>June 2009</verification_date>
	<keyword>The PK Tapimycin</keyword>
	<keyword>volunteer</keyword>
</DOC>